Anavex生命科學AVXL
那斯達克 · USD
4.65
-0.11
(-2.31%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)
Anavex生命科學AVXL
4.65
-0.11
(-2.31%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 6,782 | 10,844 | 14,459 | 12,513 | - | 14,271 | 14,538 | - | 11,293 | 12,652 |
研發費用 | 4,656 | 7,294 | 9,960 | 9,892 | 10,446 | 11,614 | 11,870 | 9,729 | 8,684 | 10,060 |
推銷及管理費用 | 2,126 | 3,550 | 4,499 | 2,621 | 3,146 | 2,657 | 2,668 | 2,705 | 2,609 | 2,592 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -6,782 | -10,844 | -14,459 | -12,513 | -13,592 | -14,271 | -14,538 | -12,434 | -11,293 | -12,652 |
其他收入及費用 | 1,119 | 1,017 | 1,216 | 1,317 | 1,481 | 2,651 | 2,448 | 2,079 | 2,756 | 2,442 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -5,663 | -9,827 | -13,243 | -11,196 | -12,111 | -11,620 | -12,090 | -10,355 | -8,537 | -10,210 |
所得稅 | 18 | - | - | - | - | - | 124 | 191 | 85 | -64 |
稅後純益 | -5,681 | -9,827 | -13,243 | -11,196 | -12,111 | -11,620 | -12,214 | -10,546 | -8,622 | -10,146 |
基本每股稅後盈餘(元) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.11 | - |
稀釋每股稅後盈餘(元) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.15 | -0.12 | -0.11 | -0.13 |
基本平均股數(千股) | 89029.00 | 85893.00 | 85380.00 | 85073.00 | 84805.00 | 84796.00 | 84535.00 | 82464.00 | 82077.00 | - |
稀釋平均股數(千股) | 89029.00 | 85893.00 | 85380.00 | 85073.00 | 84805.00 | 84796.00 | 84535.00 | 82464.00 | 82077.00 | - |
還原基本每股稅後盈餘(元) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.11 | - |
還原稀釋每股稅後盈餘(元) | -0.06 | -0.11 | -0.16 | -0.13 | -0.14 | -0.14 | -0.15 | -0.12 | -0.11 | -0.13 |
還原基本平均股數(千股) | 89,029 | 85,893 | 85,380 | 85,073 | 84,805 | 84,796 | 84,535 | 82,464 | 82,077 | - |
還原稀釋平均股數(千股) | 89,029 | 85,893 | 85,380 | 85,073 | 84,805 | 84,796 | 84,535 | 82,464 | 82,077 | - |
EBITDA(千元) | -5,663 | -9,827 | -13,243 | -11,196 | -12,111 | -11,620 | -12,090 | -10,355 | -8,537 | -10,210 |